Jbs S.A. (JBSAY) 10.6200 $JBSAY Bloomberg: JBS

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jbs S.A. (JBSAY) 10.6200 $JBSAY

Bloomberg: JBS considering IPO for U.S. business
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 8:01AM CDT


Brazil's Fire Sale
Matthew Finston - at Seeking Alpha - Mon Mar 23, 2:15AM CDT

FBZ: 13.95 (unch), MOO: 55.24 (+0.30), DBBR: 13.47 (+0.04), EWZS: 11.78 (+0.02), PBR: 7.75 (+0.21), BRAZ: 9.57 (unch), FEMS: 35.73 (+0.03), BRF: 17.56 (+0.15), FLN: 18.35 (-0.12), BRAQ: 12.66 (-0.02), EMDI: 57.71 (+1.45)

Tougher curbs may be imposed to contain Arkansas bird flu
Seeking Alpha - at Seeking Alpha - Mon Mar 16, 3:20AM CDT

BRFS: 20.80 (-0.41), PPC: 23.29 (-0.22), SFM: 35.03 (+0.03), HRL: 57.96 (-0.07), TSN: 39.38 (+0.71), PLKI: 59.18 (-0.13), BWLD: 184.89 (+2.21)

Avian bird flu in U.S. seen impacting chicken prices
Seeking Alpha - at Seeking Alpha - Sun Mar 15, 8:03PM CDT

PPC: 23.29 (-0.22), SFM: 35.03 (+0.03), HRL: 57.96 (-0.07), TSN: 39.38 (+0.71), PLKI: 59.18 (-0.13), BWLD: 184.89 (+2.21)

JBS' (JBSAY) CEO Wesley Batista on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 12, 3:32PM CDT


Potential bird flu case in Arkansas raises concerns
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 10:40AM CDT

BRFS: 20.80 (-0.41), SAFM: 79.05 (+0.29), PPC: 23.29 (-0.22), TSN: 39.38 (+0.71)

Hormel Foods (HRL) Retains Scope for Growth, Runs Risks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 05, 2:48PM CST
We have issued an updated research report on the premium meat products company, Hormel Foods Corporation (HRL) on Mar 4, 2015.
SAFM: 79.05 (+0.29), TSN: 39.38 (+0.71), HRL: 57.96 (-0.07)

New JBS deal has implications in China
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 6:21AM CST


JBS pulls food unit IPO again
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 6:11AM CST


Pilgrim's Pride (PPC) Looks Strong: Stock Up 9.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 7:44AM CST
Pilgrim's Pride Corporation (PPC) was a big mover last session, as the company saw its shares rally nearly 10%
PPC: 23.29 (-0.22)

Special Cash Dividend from Pilgrim's Pride in the Offing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 3:25PM CST
Renowned consumer goods firm Pilgrim's Pride Corporation (PPC) has taken a step forward to increase its shareholders' value through a special cash dividend of $5.77 per share.
ARMK: 31.02 (-0.12), PPC: 23.29 (-0.22), TSN: 39.38 (+0.71)

Beef imports from EU back on the menu
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 10:17AM CST

LUK: 23.07 (+0.07), CMG: 683.02 (+31.30), MCD: 97.80 (+1.25), TSN: 39.38 (+0.71), BLMN: 23.60 (+0.25), RUTH: 15.45 (-0.08), TXRH: 35.96 (+0.55), WEN: 10.72 (-0.02)

The beef industry challenges proposed dietary guidelines
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 1:43PM CST

LUK: 23.07 (+0.07), COW: 26.90 (-0.11), TSN: 39.38 (+0.71)

Pilgrim's Pride Corporation: Run Chicken Run!
Harm Elderman - at Seeking Alpha - Tue Dec 30, 1:29PM CST

PPC: 23.29 (-0.22), TSN: 39.38 (+0.71)

Sanderson Farms Q4 Earnings Miss Estimates, Up 105% Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 8:50AM CST
Sanderson Farms, Inc. (SAFM) reported earnings of $4.04 per share for fourth-quarter fiscal 2014 (ended Oct 31, 2014). The result soared 105.1% from $1.97 recorded in the year-ago quarter while lagged the Zacks Consensus Estimate of $4.21 per share.
ARMK: 31.02 (-0.12), SAFM: 79.05 (+0.29), PPC: 23.29 (-0.22)

Market Has Not Yet Noticed Potential in JBS S.A. (JBSAY); Have You? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 7:39AM CST
JBS S.A. (JBSAY) looks well positioned for a solid gain, but has been overlooked by investors lately. This Food stock has actually seen estimates rise over the past month for the current fiscal year by about 61.3%. nd if this isn’t enough, JBSAY currently carries a Zacks Rank #2 (Buy).

BRF's Operational Improvements Shining Through
Stephen Simpson, CFA - at Seeking Alpha - Thu Nov 06, 9:27AM CST

BRFS: 20.80 (-0.41), TSN: 39.38 (+0.71)

Are There Any Winners From Russia's Ban on U.S. Imports?
Rich Duprey, The Motley Fool - Motley Fool - Fri Aug 15, 10:49AM CDT
Because of the incessant saber-rattling that Vladimir Putin is conducting on the borders of the Ukraine, his annexation of Crimea, and his support for the rebels accused of shooting down a Malaysian civilian airliner, the West has joined forces and...
SAFM: 79.05 (+0.29), TSN: 39.38 (+0.71)


Asia stocks rise modestly ahead of US, China data
By YOUKYUNG LEE - AP - Mon Jul 28, 11:48PM CDT
SEOUL, South Korea (AP) — Asian stock markets posted modest gains Tuesday as investors treaded cautiously ahead of U.S. and Chinese economic reports later this week.
SNE: 30.56 (+0.66), TSN: 39.38 (+0.71), MA: 88.57 (-0.49)

Business Highlights
By The Associated Press - AP - Mon Jul 28, 4:58PM CDT
___
KO: 40.88 (-0.17), NFLX: 454.57 (+15.07), F: 16.03 (+0.08), FB: 82.04 (-0.13), DG: 76.07 (+0.40), GOOGL: 548.54 (+0.52), TSN: 39.38 (+0.71), GOOG: 540.01 (-0.77), AAPL: 127.10 (+0.54), DRI: 68.78 (+1.60), Z: 97.64 (+0.69)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 10

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 16

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 16

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
First Student Reduces Collisions by 63% with HALO Tech

Updated Category News Views 13

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 10

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 11

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 5

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 6

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 8

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex's Q3 Results Show Strong Progress Despite Market Challenges

Updated Category News Views 143

Ontex's Financial Performance for Q3 Ontex has released its latest financial results, revealing a noteworthy overall performance in the third quarter. Despite facing some challenges in consumer demand, the company reported a revenue of €445 million, marking a 3.8% year-on-year decrease when compared to comparable periods. However, when assessed against the previous...

Continue Reading
Youth Financial Independence: The Case for 16-Year-Old ISAs

Updated Category News Views 145

Empowering Youth to Manage Their Finances The conversation around financial independence for the younger generation is gaining traction. A recent campaign is advocating that the Government lowers the age for opening Individual Savings Accounts (ISAs) to 16 years old. This proposal aligns with various rights already held by young people, such as leaving school, working...

Continue Reading
Gantry Achieves Milestone with $20 Billion Loan Servicing Growth

Updated Category News Views 104

Gantry Sees Significant Increase in Q3 Loan Production Gantry, known as the largest independent commercial mortgage banking firm in the U.S., has reported impressive growth in new commercial mortgage production for the third quarter. The quarter saw a notable increase of nearly 10% over the totals from both the previous two quarters. This positive trend is bolstered by...

Continue Reading
Icahn Enterprises L.P. to Host Q3 2025 Earnings Call Discussion

Updated Category News Views 144

Upcoming Earnings Conference Call for Icahn Enterprises L.P. Icahn Enterprises L.P. (NASDAQ: IEP) has exciting news to share regarding its upcoming Q3 2025 earnings conference call. This important event will take place on a webcast, scheduled for Wednesday, November 5, 2025, at 10:00 a.m. Eastern Time. Investors and interested parties are encouraged to tune in to hear the...

Continue Reading
Iovance Biotherapeutics Announces Conference Presentations in 2025

Updated Category News Views 697

Iovance Biotherapeutics Announces Upcoming Conference Appearances Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a pioneering biotechnology firm dedicated to advancing treatments through innovative polyclonal tumor infiltrating lymphocyte (TIL) therapies, has revealed that its senior executive team will be showcasing their expertise at several prestigious conferences in...

Continue Reading